Medlive Technology Co., Ltd. (HKG:2192)

Medlive Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,567	3,845	4,358	4,187	3,879
Short-Term Investments	961.31	205.6	5.21	4.66	4.88
Trading Asset Securities	200.34	102.15	42.64	29.64	29.64
Cash & Short-Term Investments	3,729	4,152	4,406	4,222	3,914
Cash Growth	-10.20%	-5.76%	4.37%	7.87%	2531.98%
Receivables	253.52	174.85	155.92	124.21	95.87
Inventory	-	-	0.1	0.2	0.09
Other Current Assets	8.64	29.18	10.46	5.76	3.41
Total Current Assets	3,991	4,356	4,573	4,352	4,013
Property, Plant & Equipment	32.89	38.05	11.08	14.57	16.87
Long-Term Investments	864.37	440.73	42.37	92.79	0.34
Goodwill	192.53	192.53	192.53	111.52	69.72
Other Intangible Assets	40.15	29.44	27.54	16.19	9.3
Long-Term Deferred Tax Assets	8.23	8.26	8.52	8.28	6.33
Long-Term Deferred Charges	27.92	42.69	39.2	8.14	-
Total Assets	5,157	5,108	4,894	4,603	4,116

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	22.28	13.86	14.77	2.71	6.22
Accrued Expenses	87.95	79.37	74.55	62.85	45.79
Current Portion of Leases	7.91	11.6	4.55	5.14	4.21
Current Income Taxes Payable	13.89	14.69	16.97	25.03	24.22
Current Unearned Revenue	43.25	49.71	43.77	12.81	7.81
Other Current Liabilities	33.82	37.87	35.16	24.21	24.97
Total Current Liabilities	209.1	207.11	189.77	132.75	113.21
Long-Term Leases	2.2	11.03	3.64	6.13	8.96
Long-Term Deferred Tax Liabilities	9.68	8.71	7.54	4.64	2.71
Other Long-Term Liabilities	8.92	26.72	47.66	27.8	18.49
Total Liabilities	229.91	253.57	248.61	171.32	143.37

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.05	0.04
Additional Paid-In Capital	3,907	3,906	3,904	3,898	3,898
Retained Earnings	596.96	448.18	312.07	194.46	89.27
Comprehensive Income & Other	359.07	444.9	381.6	308.13	-39.01
Total Common Equity	4,864	4,799	4,597	4,401	3,949
Minority Interest	63.57	55.59	47.83	30.89	23.49
Shareholders' Equity	4,927	4,855	4,645	4,432	3,972
Total Liabilities & Equity	5,157	5,108	4,894	4,603	4,116

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	10.11	22.63	8.19	11.26	13.17
Net Cash (Debt)	3,719	4,130	4,398	4,210	3,900
Net Cash Growth	-9.96%	-6.10%	4.46%	7.94%	2754.96%
Net Cash Per Share	5.05	5.61	5.99	5.72	6.13
Filing Date Shares Outstanding	737.03	732.88	726.96	717.35	713.23
Total Common Shares Outstanding	737.03	732.88	726.96	717.35	713.23
Working Capital	3,782	4,149	4,383	4,219	3,900
Book Value Per Share	6.60	6.55	6.32	6.14	5.54
Tangible Book Value	4,631	4,577	4,377	4,273	3,870
Tangible Book Value Per Share	6.28	6.25	6.02	5.96	5.43
Machinery	19.63	9.35	8.08	7.21	5.87
Leasehold Improvements	11.7	10.67	7.07	7.07	7.07

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 30, 2026

Data Sources Report a data error